Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001085146-25-003449·Cowen Financial Products LLC
Schedule 13G ownership disclosure
UROGEN PHARMA LTD
Ordinary Shares, par value NIS 0.01 per share · CUSIP: M96088105
Event date: 2025-06-09
- Filing-level shares
- 2,652,500
- Percent of class
- 5.8%
- Cowen Financial Products LLC
Shares: 2,652,500 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-003449
- Form type
- SCHEDULE 13G
- Filer
- Cowen Financial Products LLC
- CIK
- CIK 1771015
- Filed
- Jun 13, 2025
- Reporting period
- Jun 09, 2025
- Description
- Schedule 13G beneficial ownership